Kawakami Y - Search Results

1

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.

Robbins PF, el-Gamil M, Kawakami Y, Stevens E, Yannelli JR, Rosenberg SA. Robbins PF, et al. Among authors: kawakami y. Cancer Res. 1994 Jun 15;54(12):3124-6. Cancer Res. 1994. PMID: 8205528

2

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.

Kawakami Y, Rosenberg SA, Lotze MT. Kawakami Y, et al. J Exp Med. 1988 Dec 1;168(6):2183-91. doi: 10.1084/jem.168.6.2183. J Exp Med. 1988. PMID: 3264324 Free PMC article.

3

T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.

Shilyansky J, Nishimura MI, Yannelli JR, Kawakami Y, Jacknin LS, Charmley P, Rosenberg SA. Shilyansky J, et al. Among authors: kawakami y. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2829-33. doi: 10.1073/pnas.91.7.2829. Proc Natl Acad Sci U S A. 1994. PMID: 7511820 Free PMC article.

4

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA. Kawakami Y, et al. J Exp Med. 1994 Jul 1;180(1):347-52. doi: 10.1084/jem.180.1.347. J Exp Med. 1994. PMID: 7516411 Free PMC article.

5

Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest.

Shamamian P, Mancini M, Kawakami Y, Restifo NP, Rosenberg SA, Topalian SL. Shamamian P, et al. Among authors: kawakami y. Cancer Immunol Immunother. 1994 Aug;39(2):73-83. doi: 10.1007/BF01525312. Cancer Immunol Immunother. 1994. PMID: 7519127 Free PMC article.

6

Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.

Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI. Cole DJ, et al. Among authors: kawakami y. Cancer Res. 1994 Oct 15;54(20):5265-8. Cancer Res. 1994. PMID: 7522957

7

Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.

Cole DJ, Weil DP, Shilyansky J, Custer M, Kawakami Y, Rosenberg SA, Nishimura MI. Cole DJ, et al. Among authors: kawakami y. Cancer Res. 1995 Feb 15;55(4):748-52. Cancer Res. 1995. PMID: 7531614

8

Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al. Rivoltini L, et al. Among authors: kawakami y. Cancer Res. 1995 Jul 15;55(14):3149-57. Cancer Res. 1995. PMID: 7541714 Free PMC article.

9

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

Kang X, Kawakami Y, el-Gamil M, Wang R, Sakaguchi K, Yannelli JR, Appella E, Rosenberg SA, Robbins PF. Kang X, et al. Among authors: kawakami y. J Immunol. 1995 Aug 1;155(3):1343-8. J Immunol. 1995. PMID: 7543520

10

Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides.

Salgaller ML, Afshar A, Marincola FM, Rivoltini L, Kawakami Y, Rosenberg SA. Salgaller ML, et al. Among authors: kawakami y. Cancer Res. 1995 Nov 1;55(21):4972-9. Cancer Res. 1995. PMID: 7585538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,831 results

Search Page

Filters